Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PTC Therapeutics Inc. sell Citigroup Inc.

Start price
€35.40
21.05.24 / 50%
Target price
€23.95
21.05.25
Performance (%)
-12.43%
Price
€31.60
29.08.24
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. shows a convincing performance of -12.43%. This prediction currently runs until 21.05.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
PTC Therapeutics Inc. 5.333% 5.333%
iShares Core DAX® 1.560% 2.566%
iShares Nasdaq 100 0.517% 1.894%
iShares Nikkei 225® 1.730% 5.631%
iShares S&P 500 1.482% 1.594%

Comments by Citigroup_Inc_ for this prediction

In the thread PTC Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) -12.43%
Target price 23.949
Change
Ends at 21.05.25

PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $18.00 to $26.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat

Stopped prediction by Citigroup_Inc_ for PTC Therapeutics Inc.

PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.60
27.10.23
€16.10
27.10.24
78.41%
29.08.24